Moleculin Biotech Inc

NASDAQ:MBRX   3:59:51 PM EDT
2.08
-0.11 (-5.02%)
Earnings Announcements

Moleculin Reports Qtrly Loss Per Share $0.15

Published: 11/11/2021 13:41 GMT
Moleculin Biotech Inc (MBRX) - Moleculin Reports Third Quarter 2021 Financial Results and Provides Programs Update.
Moleculin Biotech Inc - Believes Cash is Sufficient to Meet Projected Operating Requirements Into 2024.
Moleculin Biotech Inc - Qtrly Loss per Share $0.15.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.21

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.22

More details on our Analysts Page.